HRID434801

反应详情

EQUATION

反应方程式

HRID 434801 的结构方程式

AUXILIARIES

试剂、催化剂与溶剂

1

PROCEDURE

实验过程

Camptothecin (100 mg, 0.287 m-mol) was suspended in methanol (25 ml) and then dissolved therein by addition under ice-cooling of 75% sulfuric acid (10 ml). To the solution was added dropwise under reflux with stirring an aqueous solution (100 ml) of ammonium persulfate (15 g, 0.0657 mol) over 16 hours. The reaction mixture was poured into ice water (100 ml) and the organic matter was extracted with a mixture (1:1, 500 ml) of dioxane-chloroform and then thrice with chloroform (100 ml×3). The organic phases were combined, dried with anhydrous magnesium sulfate, filtered and then evaporated until dryness under reduced pressure. The remaining solid having an orange color was warmed (50°-60° C.) with methanol (200 ml) and stirred for 30 minutes. An insoluble matter was collected by filtration, dried under reduced pressure and recrystallized from dimethylformamide-dioxane whereupon 40 mg (36.9%) of 7-hydroxymethylcamptothecin were obtained as light yellow white prismatic crystals having a melting point of 274°-276° C. (dec.). Rf value 0.125 (5% methanol-chloroform).

WORKUP

后处理

  1. dissolutiondissolved
  2. additionby addition under ice-
  3. additionTo the solution was added dropwise
  4. temperatureunder reflux
  5. extractionthe organic matter was extracted with a mixture (1:1, 500 ml) of dioxane-chloroform
  6. dry with materialdried with anhydrous magnesium sulfate
  7. filtrationfiltered
  8. customevaporated until dryness under reduced pressure
  9. temperaturewas warmed (50°-60° C.) with methanol (200 ml)
  10. filtrationAn insoluble matter was collected by filtration
  11. customdried under reduced pressure
  12. customrecrystallized from dimethylformamide-dioxane whereupon 40 mg (36.9%) of 7-hydroxymethylcamptothecin
  13. customwere obtained as light yellow white prismatic crystals